THE WHAT? David Greenberg has been appointed as CEO of L’Oréal USA and President of North America Zone, effective immediately.
THE DETAILS Greenberg will also be a member of L’Oréal Executive Committee, and will succeed Stéphane Rinderknech.
Rinderknech is said to have “decided to continue his career outside of the Group.”
Greenberg is currently President of L’Oréal Professional Products Division in North America, having spent more than 28 years in leadership roles at L’Oréal across markets, divisions, brands and functions.
Prior to his current role, Greenberg served as President of Maybelline, Garnier and Essie within L’Oréal USA’s Consumer Products Division for eight years and directed marketing for the L’Oréal Paris brand for a further six years.
THE WHY? Commenting on Greenberg’s appointment, Nicolas Hieronimus, CEO of L’Oréal, stated: “I have known David for many years. David is one of the architects of L’Oréal’s rise to become the market leader in the US, and he still leads with the same entrepreneurial, innovative and competitive mindset.
“He is a successful team builder. I am very proud to name the first American to head the North America Zone and to join our Groupe’s Executive Committee. North America Zone is one of our biggest engines of growth and David is the right person to take our team and business to new heights.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
